Printed From:

HEAR MORE ON EMERGING SCIENCE IN ATOPIC DERMATITIS FROM EXPERTS IN THE FIELD

SUBCLINICAL DEFECTS

CHRONIC INFLAMMATION

KEY TH2 CYTOKINES

This educational program has been developed by Regeneron Pharmaceuticals and Sanofi Genzyme. The speakers have been compensated for their time and effort.